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SUMMARY 
 
We recently reported a novel method to induce ES cells differentiate into an endodermal fate, 
especially pancreatic, using a supporting cell line.  Here we describe the modified culture 
condition with the addition and withdrawal of secreted growth factors could induce ES cells to 
selectively differentiate into a hepatic fate efficiently.  The signaling of BMP and FGF that have 
been implicated in hepatic differentiation during normal embryonic development are 
demonstrated to play pivotal roles in generating hepatic cells from the definitive endoderm 
derived from ES cells.  Moreover, the expression of AFP, Albumin or a biliary molecular 
marker appeared sequentially thus suggested the differentiation of ES cells recapitulated normal 
developmental processes of liver.  The ES cell-derived differentiated cells demonstrated 
evidence of glycogen storage, secreted Albumin, exhibited drug metabolism activities and 
expressed a set of cytochrome or drug conjugate enzymes, drug transporters specifically 
expressed in mature hepatocytes.  With the same procedure, human ES cells also gave rise to 
cells with mature hepatocytes' characteristics.  In conclusion, this novel procedure for hepatic 
differentiation will be useful for elucidation of molecular mechanisms of hepatic fate decision at 
gut regionalization, and could represent an attractive approach for a surrogate cell source for 
pharmaceutical studies such as toxicology. 
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INTRODUCTION 
 
Liver performs many complex functions including carbohydrate metabolism, urea and lipid 
metabolism, storage of essential nutrients, production and secretion of bile acids, into which 
metabolites of drugs and other compounds are excreted.  Hepatic biotransformation of a drug 
involves activations of inactive prodrugs to active drugs, inactivations, detoxifications as well as 
adverse activations, where some metabolites are more toxic than the parent drug molecules. 
Therefore, the examination of drug biotransformation using human liver cells plays an important 
role in the early stages of the drug discovery process.  However, primary liver cells are 
short-lived and cannot be maintained in culture for long term.  Considerable donor dependent 
variations are also problematic.  Embryonic stem (ES) cells are pluripotent cells derived from 
the inner cell mass of the blastocysts.  They apparently differentiate into various types of 
mature cells, thereby are attractive source for routine access to large numbers of cells that can be 
used for the development of new drug-screening strategies instead of primary cells (Davila et al. 
2004; Kulkarni & Khanna 2006).  
The vertebrate liver develops from the ventral foregut endoderm (Wells & Melton 1999; Zaret 
2000).  Although several lines of evidences have shown that different regions of the gut are 
patterned by signals from the underlying mesoderm, the mechanism of how specific endoderm 
tissues differentiate remains much unknown.  In hepatic development, Fibroblast growth factors 
(FGF) and Bone morphogenetic proteins (BMP) originated from the cardiac mesoderm and the 
septum transversum mesenchyme are shown to be essential for cardiac induction, promotion of 
liver gene expression and endoderm proliferation (Jung et al. 1999; Rossi et al. 2001).  FGF 
signaling from the cardiac mesoderm directs the overlying ventral endoderm to adopt a hepatic 
fate instead of a pancreatic fate (Deutsch et al. 2001).   
Several studies reported the induction of ES cell differentiation into hepatic cells both in vitro 
and in vivo.  The in vitro approaches involve the formation of embryoid bodies to mimic the 
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inductive microenvironment required for liver organogenesis (Asahina et al. 2004; Heo et al. 
2006) or treatment with specific growth factors and cytokines critical for hepatocyte 
differentiation (Teratani et al. 2005).  Also the co-cultivation of ES cells with embryonic 
mesenchymal cells was shown to direct ES cells toward a hepatic lineage (Ishii et al. 2005; Saito 
et al. 2006; Soto-Gutierrez et al. 2006).  Recently, in vitro generation of ES cell-derived hepatic 
cells was reported by using BMP4 (Gouon-Evans et al. 2006).  Although these findings are 
encouraging, there are few studies for fate divergence from gut endoderm into liver, pancreas 
and intestine cells.  Hepatic differentiation of ES cells in most studies was not efficient for 
producing enough amounts of functional mature hepatocytes. 
 We have established a novel procedure to direct ES cells differentiate into regional specific 
gut endoderm lineages, such as liver, pancreas, lung or intestine, by co-cultivation with a 
supporting mesoderm-derived cell line, M15, with selective culture conditions.  Using this 
novel procedure, the present study documents an efficient induction of ES cells into 
morphologically, and biologically functional hepatocytes.  Moreover, this method was 
applicable to human ES cells.  Under selective culture conditions, approximately 80% of the 
human ES cells can be manipulated to differentiate into AFP-positive cells, and 9% of total cells 
turned to Albumin-positive cells.  Analysis of the hepatic cells derived from ES cells showed 
that these cells resemble mature hepatocytes in that they store glycogen, and expressed various 
molecular markers such as Albumin, bile acid transporters, cytochrome P450 metabolic 
enzymes.  
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RESULTS 
M15, a mesoderm-derived cell line, directs ES cells to differentiate into endodermal and 
hepatic lineages 
We have recently established a co-cultivation method using a mesoderm-derived cell line, 
M15. ES cells grown on M15 and treated with Activin and bFGF during the first 4 days of 
differentiation, are sequentially directed to differentiate into mesendoderm and then into 
definitive endoderm. A prolonged addition of Activin and bFGF on d4-8 specifically increased 
pancreatic differentiation marked by an increase in Pancreatic and duodenal homeobox gene 1 
(Pdx1)-expressing cells, while the withdrawal of Activin and bFGF induced α-fetoprotein (Afp) 
expression (Shiraki et al. 2008).  
 In an attempt to find a condition in which ES cells dominantly adopt a hepatic fate   
instead of a pancreatic fate, Activin and bFGF were added to ES cells grown on M15 on d0-4, 
and then withdrawn.  On d4-8, various soluble factors were examined, in combination with 
media supplemented with FBS or KSR, with varied glucose concentrations (2000 mg/L or 4500 
mg/L).  Hepatocyte growth factor (HGF), Oncostatin M (OsM), or dexamethasone (Dex) were 
included since these were reported to potentiate hepatic differentiation of ES cells 
(Michalopoulos et al. 2003; Teratani et al. 2005).  
 On day 8, both definitive endoderm and pancreatic cells were quantified by flow cytometry 
using E-cadherin+/Cxcr4+ (Yasunaga et al. 2005), and Pdx1 as markers, respectively.  To 
quantify Pdx1 expression, we used an ES cell line, SK7, established from a transgenic mouse 
line P#48.9 (Gu et al. 2004) bearing a Green fluorescent protein (GFP) reporter driven by the 
promoter for Pdx1 (Shiraki et al. 2008).  Figure 1A shows that the proportion of both the 
E-cadherin+/Cxcr4+ cells and GFP+ (Pdx1-expressing) cells increased when Activin and bFGF 
were added on d4-8 (Fig 1A, filled bars). The addition of Dex, HGF and OsM decreased the 
proportion of E-cadherin+/Cxcr4+ cells as well as Pdx1-expressing cells (Fig. 1A).  
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To define the extent of hepatic differentiation within gut definitive endoderm, we quantified 
transcript levels for Afp, an early hepatic marker (Shiojiri 1981), and Sonic hedgehog (Shh), 
which is expressed in the foregut region but excluded in the pancreatic and hepatic buds (Burke 
& Oliver 2002)(Fig. 1B).  Afp was induced under KSR, but not FBS condition.  Moreover, 
under low glucose condition, and with the presence of Dex, HGF and OsM, the definitive 
endoderm cells turned out to give a maximum expression of Afp (gray bar in 2000KSR).  When 
Activin and bFGF are added, a pancreatic fate is favored, shown by an increase in Pdx1/GFP 
positive cells (Fig. 1A, black bars), and a decrease in Shh and Afp transcripts (Fig. 1B, black 
bars). Conversely, when Dex, HGF and OsM were added, a non-pancreatic fate is favored (Fig. 
1A, 1B, gray bars). 
Immunocytochemistry (ICC) further confirmed that culture conditions for the generation of 
Pdx1- and AFP-expressing cells are mutually complementary and most of them arose from 
distinct colonies (Fig. 2A). Continuous addition of Activin and FGF yielded Pdx1-expressing 
cells dominantly (Activin & bFGF columns).  Withdrawal of these factors followed by the 
addition of Dex, HGF and OsM in medium supplemented with a lower glucose concentration of 
2000 mg/L and KSR instead of FBS yielded a substantial number of AFP expressing cells in the 
expense of Pdx1-expressing cells (2000KSR, Dex&HGF&OsM).  The present result that 
hepatic differentiation is enhanced under serum free condition agrees well with previous 
reports(Kubo et al. 2004; Heo et al. 2006).  
Either the single or the combinatory additions of Dex, HGF and OsM were examined with 
medium supplemented with KSR and lower glucose (2000 mg/L).  Figure 2B shows that the 
effects of promoting AFP expression is in an order of Dex > HGF > OsM.  Addition of Dex and 
HGF was enough to result in a maximum potentiation of ES cell differentiation into 
AFP-expressing cells.  
Therefore, for maximum definitive endoderm differentiation, the following procedure was 
adopted: ES cells are cultured for 4 days (d0-d4) in a medium with Activin , bFGF, FBS, and 
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high glucose (4500 mg/L), then the medium is switched to that with KSR, low glucose (2000 
mg/L) and various growth factors and their inhibitors of interest. 
 
BMP and FGF signals are pivotal for hepatic differentiation of the definitive endoderm 
from ES cells 
Since it is reported that BMP and FGF signaling are involved in hepatic differentiation (Jung 
et al. 1999; Rossi et al. 2001), their effects on definitive endoderm cells were tested (Fig. 2C, D).  
Addition of bFGF increased AFP-positive cells, whereas addition of SU5402, a specific inhibitor 
of FGF receptor I, decreased AFP-positive cells.  Noggin addition abolished most of the 
AFP-expressing cells, which was recovered by bFGF addition (Fig. 2C, D).  These results 
demonstrate that BMP signaling is required in the induction of hepatocyte differentiation, while 
FGF signaling potentiates BMP signal.   
 
Chronological analysis revealed a sequential induction of molecular markers 
demonstrating the differentiation of hepatoblasts and hepatocytes, and cells of the bile duct 
cell lineages. 
The cultures were then extended up to d30 and the chronological expressions of hepatic 
molecular markers were studied.  Figure 3A shows that AFP single positive cells first appeared, 
and then Albumin-positive cells are detected on d18.  On d18, there are cells expressing both 
AFP and Albumin.  Later on, the proportion of AFP-expressing cells decreased, and 
Albumin-expressing cells increased.  On d8 and d30, the proportions of AFP-positive cells were 
33.1% and 7.4%, respectively (Supplementary Table 2).  The results that AFP and Albumin are 
differentially regulated suggest that the ES cells differentiate to immature hepatic precursors 
(AFP+/Albumin-), then hepatoblast (AFP+/Albumin+), and then hepatocyte (AFP-/Albumin+), 
which appears to be coincident with the development of hepatic lineages in mouse embryos 
(Shiojiri 1981, 1984). 
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Since the hepatoblasts are bipotential progenitors capable to differentiate into hepatocyte and 
bile duct lineages, we then assayed for the generation of bile duct lineage in the culture.  ICC 
analysis on d30 showed that cells of the hepatocyte lineage and bile duct lineage segregated and 
formed distinct colonies of Albumin+ (17.8%) or Dolichos biflorus agglutinin (DBA)+ (72.9%) 
(Takahashi et al. 1995)(Fig. 3B, Supplementary Table 2).  
At the same time, ICC analysis of mature molecular markers showed that some of the 
Albumin-positive cells expressed mature hepatic markers such as α-1-Antitrypsin, and two 
members of the cytochrome P450 (Cyp) enzymes Cyp3A or Cyp7A1 (Fig. 3C).  
α 1-Antitrypsin (Travis & Salvesen 1983; Potempa et al. 1994) is a serine protease and trypsin 
inhibitor, Cyp3A is a member of the cytochrome P450 subfamilies involved in drug and steroid 
metabolism (Wrighton & Stevens 1992), Cyp7A1 is a cholesterol 7 alpha hydroxylase and 
regulates the pathway through which cholesterol is converted into bile acids.  Cyp7A1 is 
expressed in the liver and not in the yolk sac tissue, and thus serves as a good marker for 
hepatocytes (Asahina et al. 2004). 
 
Functional characterization of the ES cell-derived hepatic cells 
To define the extent of maturation of the hepatic cells, real-time PCR analysis of hepatic 
molecular markers were carried out on d10 and d30 differentiated ES cells (Fig. 4).  The 
expression levels of the molecular markers were compared with those in E12.5 fetal liver or 
adult liver.  At E12.5, fetal liver also acts as hematopoetic tissue and is rich in hematopoetic 
cells.  CD45-/Ter199- (double negative) E12.5 fetal liver cells were recovered and subjected to  
real-time PCR analysis (Fig. 4, FL).  Afp transcripts decreased at day 30, which agrees well 
with the above ICC data (Fig. 3, Supplementary Table 2).  Transcripts of Alb1, Keratin 7 
(Cytokeratin 7; Krt 7), Keratin 19 (Cytokeratin 19; Krt19), or mature markers of cytochrome 
P450 enzyme Cyp7a1, Cyp2b10, Cyp3a11, Cyp3a13, hydroxysteroid sulfotransferase (Sult2a1), 
UDP-glucuronosyltransferase (Ugt1a1), organic anion transporting polypeptides (Slco1a4) or 
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bile salt export pump (Abcb11) (Choudhary et al. 2003; Wagner et al. 2005) were also examined 
(Fig. 4).  These mature hepatocyte markers were detectable at d10, which increased to a 
substantial level at d30 of differentiation.  Most of the expression levels of the markers were 
comparable to those of the fetal liver.  Ugt1a1, Cyp7a1, Cyp2b10, Cyp3a13 and Slco1a4 
expressions were higher than those of fetal liver, but lower than those of adult liver.  These 
results thereby demonstrate that the ES cell-derived differentiated cells expressed many of the 
mature hepatocyte markers. 
Next we performed functional studies to characterize the ES cell-derived hepatic cells.  In 
mouse embryo, a small proportion of hepatocytes begin to accumulate glycogen in the cytoplasm 
from E15.5, and then hepatocytes rich in glycogen increased in number in the liver of E16.5 and 
E17.5 (Shiojiri 1981).  Most cells on d30 of differentiation were positive for Periodic acid 
Schiff (PAS) staining indicative of glycogen storage, a characteristic of mature hepatocytes (Fig. 
5A, d30).  
Since OsM is reported to induce maturation of mouse fetal hepatocytes (Kamiya et al. 2001; 
Kamiya et al. 2002), the effect of OsM on Albumin secretion was assayed with an 
enzyme-linked immunosorbent assay (ELISA).  Figure 5B showed that the Albumin secretion 
was not detected at d8 when hepatoblast-like (AFP+/Albumin+) cells appeared (Fig. 3).  The 
potentiation effect of OsM on Albumin secretion was not observed until d40 of differentiation.  
At d50 and d60, a two-fold increase in Albumin secretion was detected in OsM, Dex and HGF 
supplemented differentiation media compared to control media supplemented with Dex and 
HGF.  
Cyp3A4 is known to be involved in the metabolism of more than half of all currently used 
drugs.  Several well-documented cases exhibiting clinically important drug-drug interactions 
and toxicities are implicated to be related to Cyp3A4 inhibition.  Cyp3a11 and Cyp3a13, two 
important Cyp3A isoforms identified in the mouse, are expressed in differentiated ES cells (Fig. 
4).  Cytochrome P450 3A activity of ES cells differentiated for 60 days was tested (Fig. 5C).  
 10
ES cell-derived hepatic cells (d60) exhibited metabolic activities approximately one fifth of that 
of adult liver (AL).  These data are consistent with real-time PCR results (Fig. 4).   
 
Application to human ES cells  
To test if the present culture procedure could be applied to human ES cells, KhES-1 cells 
were treated at d0 to d10 with Activin and LY294002, a potent PI3 kinase inhibitor, which was 
shown to efficiently promote endoderm differentiation from undifferentiated ES cells (McLean et 
al. 2007). Since there is evidence for a role of the FGF singling pathway in maintaining 
pluripotency of human ES cells (Amit et al. 2000), bFGF was not used in the present procedure 
for differentiation of human ES cells although it promoted endoderm differentiation in mouse ES 
cells. 
Figure 6A shows the expression levels of the transcripts of endoderm or hepatic markers in 
human ES cell-derived differentiated cells (d18, d30).  An endoderm marker, Sox17 as well as 
Afp, Alb, Cytokeratin 7 (CK7), Cytokeratin 18 (CK18), Cytokeratin 19 (CK19) and Cyp7a1 were 
detected in differentiated ES cells on d18.  On d30, the expression of Afp decreased, along with 
a marked increase in Alb expression.  ICC analyses demonstrate that AFP is induced in 
approximately 40% of total cells on d14 (Fig. 6B, Supplementary Table 2).  Addition of Dex, 
HGF at d10 and thereafter increased the proportion of AFP-expressing cells with concomitant 
decrease in Oct3/4 expressing undifferentiated ES cells (Supplementary Table 2).  Albumin 
positive cells are detected on d18, where there are cells expressing both AFP and Albumin (Fig. 
6B).  The proportion of AFP-expressing cells decreased much more slowly comparing with 
mouse ES cells (Supplementary Table 2).  On d30, colonies of Albumin single positive cells, 
which did not express AFP, become evident (Fig. 6B).  On d20, approximately 80% of the 
human ES cells differentiated into AFP-positive cells, and on d40, 9% of total cells were 
Albumin-positive hepatocytes.  These results suggest that the human ES cell-derived hepatic 
cells differentiate sequentially to form hepatocyte precursor, hepatoblast, and then hepatocyte or 
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bile duct lineages similarly with that observed in mouse ES cells, but there were differences in 
the length of time window required for the process of maturation.  
Next, to examine the extent of maturation of the human ES cell-derived hepatic cells, hepatic 
molecular markers were analyzed by quantitative PCR with d18 and d50 cultures (Fig. 7A).  
The expression levels of the molecular markers were compared with those in 22 – 40 weeks old 
fetal liver or adult liver.  Afp was expressed on d18, and decreased on d50.  The expression 
level on d50 was much higher than that of fetal liver.  The mature hepatocyte markers such as 
Albumin (Alb), Cyp3a4, liver-specific organic anion transporting polypeptides 1B1 (Oatp1b1) 
(Hsiang et al. 1999; Konig et al. 2000) were detected on d18 and increased to a substantial level 
on d50 (Fig. 7A).  Most cells on d24 and d50 were PAS positive, demonstrating glycogen 
deposition (Fig. 7B).  
Ultrastructures of the differentiated human ES cells grown for 50 days were evaluated by 
electron microscopy (Fig.7C-E).  ES cell-derived cells were rich in organella such as 
mitochondria (Mt), endosome (En), lysosome (Ly), rough ER (rER), Golgi apparatus (Go), being 
consistent with typical hepatocytes with active protein synthesis (Fig 7C-E).  In addition, some 
of the cells formed biliary canaliculi (Bc) with microvilli associated with intracellular filament 
(Fi) and cell junctional complexes (arrows) (Fig. 7C).  Consistent with results from PAS 
staining, most of ES cell-derived cells were rich in glycogen granules (g), and convoluted form 
of smooth endoplasmic reticulums (sER) were also found in the cytoplasm (Fig. 7D).  
Furthermore, some of these cells showed characteristic epithelial like structure with polarization 
(Fig. 7E); well-developed microvilli were prominent on the one side of the cell surface (Fig. 7E 
arrowhead), and cell junction complex also observed on the lateral side (Fig. 7E arrow).  These 
results indicate that ES cell-derived hepatic cells show normal hepatocyte ultrastructure. 
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DISCUSSION 
We previously reported a novel procedure for in vitro differentiation of ES cells into definitive 
endoderm lineages by growing ES cells on a supporting cell line, M15, and that by modification 
of the culture condition, the differentiation efficiency of ES cell into Pdx1-expressing cells 
markedly increased (Shiraki et al. 2008).  The molecular mechanism for each inductive process 
during the entire differentiation procedure was extensively studied(Shiraki et al. 2008).  With 
this information, we are able to optimize the condition for selective induction of hepatic fate 
versus a pancreatic fate of the definitive endoderm at a high efficiency (Fig. 1).  Several groups 
have recently reported the differentiation of ES cells into hepatic cells (Gouon-Evans et al. 2006; 
Soto-Gutierrez et al. 2006; Cai et al. 2007).  However, this is the first report demonstrating the 
expression of mature hepatocytes markers of various transporters and metabolizing enzymes, 
such as Sult2a1, Ugt1a1, Cyp7a1, Cyp2b10, Cyp3a11, Cyp3a13, Slco1a4, Abcb11 (Fig. 4).  
Moreover, under present culture condition, the mature hepatocytes can be maintained over 60 
days in vitro (Fig. 5).  
During mouse development, the induction of hepatic genes occurs about E8.5 (Lemaigre & 
Zaret 2004), and it requires FGF signaling from adjacent cardiac mesoderm (Jung et al. 1999) 
and BMP2&4 from the septum transversum mesenchyme cells (Rossi et al. 2001).  Then the 
endoderm starts to bud out into the stromal environment, where they interact with endothelial 
cells (Matsumoto et al. 2001).  When the hepatic endoderm is specified, they are referred to as 
hepatoblasts (Lemaigre & Zaret 2004).  The bipotential hepatoblasts are capable of 
differentiating into hepatocytes or bile duct cells.  Our results suggest that hepatic 
differentiation is enhanced under serum free condition which agrees with previous reports (Kubo 
et al. 2004; Heo et al. 2006) that serum inhibits hepatic differentiation.  It is also demonstrated 
that removal of serum strongly enhanced hepatic induction while inhibiting Pdx1 expression, 
indicating that there were unknown serum factors inhibiting hepatic differentiation (Fig. 1 and 2).  
We found that the treatment of Dex, HGF and OsM under serum containing conditions elevated 
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the expression level of Shh, but not Afp in mouse ES cells (Fig, 1B).  Shh is expressed in the 
foregut but not pancreatic or hepatic epithelia. Therefore these results suggested that 
endoderm-derived cells other than pancreas and liver were differentiated under the above culture 
condition.  Taken together, our differentiation systems using M15 provide a good tool for 
investigation of regionalization of gut endoderm in vitro. 
We also examined the effects of BMP, bFGF and their antagonists, Noggin or SU5402 (Fig. 
2A, B).  While bFGF increased AFP-expressing cells, SU5402 decreased.  Noggin completely 
abolished AFP-expressing cells, and this was rescued by bFGF, demonstrating that BMP4 and 
bFGF are both required for hepatic differentiation.  The addition of BMP did not show 
potentiation effects on the formation of AFP positive cells in this study (Fig. 2C, D). We 
speculated that endogenous BMP secretion from M15 cells, in which Bmp4 is highly expressed 
(Shiraki et al. 2008), is sufficient.  The above results agree with a recent report that in vitro 
generation of ES cell derived hepatic cells requires BMP4 (Gouon-Evans et al. 2006), and are 
consistent with previous reports using mouse embryo (Jung et al. 1999; Rossi et al. 2001), 
thereby suggesting that in vitro hepatic differentiation using our method recapitulates the mouse 
hepatic development. 
 HGF has been reported as a regulator of hepatoblast bipotency (Suzuki et al. 2002; Suzuki et 
al. 2003).  Dexamethasone is a synthetic glucocorticoid hormone active in induction of 
enzymes concerned in gluconeogenesis in the liver (McGrane et al. 1990; Michalopoulos et al. 
2003).  In our present studies, HGF and dexamethasone promoted expression of AFP and 
Albumin (Fig. 2).  Afp transcription was reported to start soon after fertilization, whereas the 
Alb1 transcripts was detected by RT-PCR, at the earliest, on E13.5 (Petkov et al. 2004).  Our 
present results show a temporally correlated expression pattern of Afp and Alb (Fig. 3) thereby 
indicating recapitulation of normal liver embryonic developmental program.  DBA 
lectin-positive bile duct cells were also generated from ES cells, indicating that the present 
procedure could induce cells of the hepatic lineages, including bile duct cells and hepatocytes 
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(Fig. 3).  Enzymes function in the detoxification pathway; such as Sult2A, Ugt1A, Cyp2b10, 
Cyp3a11 and Cyp3a13, are induced (Fig. 4).  Biochemical analyses indicated that ES 
cell-derived hepatocytes deposited glycogen, which are characteristics of normal mature 
hepatocytes (Fig. 5A).  
On the other hands, most of the genes expressed in the hepatic cells are also expressed in the 
extra embryonic yolk sac tissue.  AFP and Albumin, which are widely used as hepatic marker, 
are also expressed in both tissues.  In order to discriminate between these two populations of 
cells, ICC of Cyp7a1, a hepatocyte specific marker which is not expressed in the extraembryonic 
yolk sac tissue, was performed.  As shown in Figure 3C and 6A, both mouse and human ES 
cell-derived differentiated cells expressed Cyp7A1, thereby suggesting that Albumin-positive 
cells derived from ES cells are hepatic cells but not extra embryonic cells. 
Maturation of the liver is reported to be governed by cytokine signaling (Matsumoto et al. 
1994; Kinoshita & Miyajima 2002).  Studies using hepatoblast culture system have shown that 
OsM, which is secreted from hematopoietic cells within the fetal liver, contributes to control late 
stages of hepatocyte differentiation (Kamiya et al. 1999; Kamiya & Gonzalez 2004).  Albumin 
secretion assay suggests that OsM promotes hepatic maturation in our differentiation systems 
(Fig. 5B). Finally ES cell-derived hepatic cells grown with Dex, HGF and OsM for 60 days 
exhibit some extents of drug metabolism activity (Fig. 5C). 
A human ES cell line, KhES-1 (Suemori et al. 2006), was also subjected to the similar 
procedure as mouse ES cells and cultured on M15 cells as a supporting cell.  KhES-1 gave rise 
to abundant AFP-positive cells, and by combination of growth factors, they expressed AFP and 
Albumin in a sequential way similar to that of mouse ES cells.  This suggests that KhES-1 cells 
adopt similar pathway toward hepatocytes (Fig. 6A, B).  Additionally, the results of PAS 
staining, quantitative PCR analysis and transmission electron microscopy suggest that human ES 
cell-derived cells have the characteristics of mature hepatocytes (Fig. 7). 
In conclusion, the use of M15 as supporting cells for the differentiation of ES cells has been 
 15
proven to be a powerful tool for regulating ES cell differentiation especially into endodermal fate.  
The differentiation process recapitulates normal development, thus helps understanding the 
molecular mechanism of the processes of induced differentiation of cells of the endoderm 
lineages.  The applicability of this method to human ES cells would yield the potential tools for 
drug discovery or regenerative medicine in the future. 
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EXPERIMENTAL PROCEDURE 
ES cell lines 
The mouse ES cell line, SK7, containing a Pdx1 promoter-driven GFP reporter transgene, was 
established by culturing blastocysts obtained from transgenic mice homozygous for the 
Pdx1/GFP gene(Shiraki et al. 2008).  The SK7 ES cell line was maintained on mouse 
embryonic fibroblast (MEF) feeders in Glasgow minimum essential medium (Invitrogen) 
supplemented with 1000 units/ml leukemia inhibitory factor (LIF; Chemicon), 15% Knocked-out 
Serum Replacement (KSR; Gibco), 1% fetal bovine serum (FBS; Hyclone), 100 μM nonessential 
amino acids (NEAA; Invitrogen), 2 mM L-glutamine (L-Glu; Invitrogen), 1 mM sodium 
pyruvate (Invitrogen), 50 units/ml penicillin and 50 μg/ml streptomycin (PS; Invitrogen) and 
100 μM β-mercaptoethanol (β-ME; Sigma).  The human ES cells (KhES-1) (Suemori et al. 
2006) were a gift from Dr. N. Nakatsuji and Dr. H. Suemori (Kyoto University, Kyoto, Japan) 
and were used following the hES cell guidelines of the Japanese government.  Undifferentiated 
hES cells were maintained on a feeder layer of MEF in DMEM/F12 (Sigma) supplemented with 
20% KSR, L-Glu, NEAA and β-ME under 3% CO2.  To passage hES cells, hES cell colonies 
were detached from the feeder layer by treating them with 0.25% trypsin and 0.1 mg/ml 
collagenase IV in PBS containing 20% KSR and 1 mM CaCl2 at 37°C for 5 min, followed by 
adding culture medium and disaggregating ES cell clumps into smaller pieces (5-20 cells) by 
gentle pipetting several times.  
 
Supporting cells 
The mesonephric cell line M15, which expresses WT1, was established from mouse 
mesonephros overeexpressed with the large T protein of polyoma virus under the control of the 
early viral enhancer.  M15 cells (Larsson et al. 1995) was kindly provided by Dr. T.Noce 
(Mitsubishi Kagaku Institute of Life Science, Tokyo, Japan) and Dr. M.Rassoulzadegan 
(University of Nice-Sophia Antipolis, Antipolis, France). M15 cells (Larsson et al. 1995) were 
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grown in DMEM supplemented with 10% FBS.  M15 cells were treated with mitomycin C at 
10 μg/ml for 2.5 hr before use.  M15 were seeded on gelatin-coated 6-well or 24-well plates at a 
concentration of 8 x 105 cells or 2 x 105 cells per well, respectively.  
 
Growth factors and inhibitors 
Reagents were purchased and used at the designated concentrations as followings; 
recombinant human activin-A (R&D Systems), 20 ng/ml; recombinant human bFGF (Peprotech), 
50 ng/ml; recombinant human BMP4 (R&D Systems), 50 ng/ml; LY294002 (Calbiochem), 10 
μM; SU5402 (Calbiochem), 10 μM; recombinant mouse Noggin/Fc Chimera (R&D Systems), 
100 ng/ml;. recombinant human Hepatocyte Growth Factor (HGF, Peprotech), 10 ng/ml; 
Dexamethasone (Dex, Sigma), 1 μM; recombinant human Oncostatin M (OsM, Sigma). 
 
Differentiation of ES cells 
For differentiation studies, ES cells were plated at 5,000 or 20,000 cells per well in 24-well or 
6-well plates (Nunc), respectively, that had been previously coated with M15 cells. The cells 
were cultured in differentiation medium supplemented with 10%FBS and 4500 mg/L glucose on 
d0 - d4, and were switched to 10%KSR and 2000 mg/L glucose at d4 and on, in DMEM with 
NEAA, L-Glu, PS and β-ME for up to 60 days.  Activin A (20 ng/ml) and bFGF (50 ng/ml) 
were added on d0 - d4 of differentiation (Shiraki et al. 2008), withdrawn and switched to as 
noted in the text on d4 and on.  Media were replaced every 2 days with fresh medium 
supplemented with growth factors. 
In the case of human ES cells, KhES-1 cells were plated at 20,000 or 80,000 cells per well 
in 24-well or 6-well plates, respectively, that had been plated with M15 cells.  ES cells were 
cultured in differentiation medium (DMEM supplemented with 10% KSR, 4500 mg/L glucose, 
NEAA, L-Glu, PS and β-ME) for up to 50 days.  Activin A (20 ng/ml) and LY294002 (10 μM) 
were added on d0-d10 of differentiation, HGF (10 ng/ml) and Dex (1 μM) were added on d10 - 
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d50. Media were replaced every 2 days with fresh differentiation medium supplemented with 
growth factors.  
 
Flow cytometry analysis 
Either of the following antibodies were used: biotin-conjugated anti-E-cadherin monoclonal 
antibody (mAb) ECCD2 (Shirayoshi et al. 1986), biotin-conjugated anti-CD45 mAb B220 
(eBioscience), biotin-conjugated anti-TER-119 mAb (eBioscience) or phycoerythrin 
(PE)-conjugated anti-Cxcr4 mAb 2B11 (BD Biosciences Pharmingen).  The stained cells were 
analyzed with a FACS Canto (BD) or purified with FACS Aria (BD).  Data were recorded with 
the BD FACS Diva Software program (BD) and analyzed using the Flowjo program (Tree Star). 
 
RT-PCR analysis 
RNA was extracted from ES cells or mouse liver using RNeasy mini-kit (Qiagen) and then 
treated with DNase (Qiagen).  Human fetal (22-40 weeks old) and adult (51 years old) liver 
total RNA were purchased from Clontech Laboratories, Inc.  For reverse transcription reactions, 
3 μg RNA was reverse-transcribed using MMLV reverse transcriptase (Toyobo) and oligo dT 
primers (Toyobo).  One μl of 5-fold diluted cDNA (1% of the RT product) was used for PCR 
analyses. The primer sequences for each primer set are shown in Supplementary Table 1 in the 
supplementary material. For real-time PCR analysis, the mRNA expression was quantified with 
SyberGreen on an ABI 7500 thermal cycler (Applied Biosystems).  The level of each gene 
expression was normalized with that of β-actin. The PCR conditions were as follows: 
denaturation at 95°C for 15 sec, annealing and extention at 60°C for 60 sec, for up to 40 cycles.  
Each measurement were normalized to ß-actin (mouse) and GAPDH (human) for each sample by 
subtracting the average ß-actin (mouse) and Gapdh (human) Ct values (Threshold Cycle) from 
the average Each gene Ct, resulting in Ct.  Each target mRNA levels, expressed as arbitrary 
units, were determined by standard curve method. 
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Immunocytochemistry 
For whole-mount immunocytochemistry, ES cells were plated on 24-well Thermanox cover 
slips (Nunc).  Confocal images were obtained using a TCS-SP2 Spectral Confocal Scanning 
System (Leica). Phase contrast images were obtained using IX71 Inverted Microscope 
(Olympus).  The following antibodies were used to detect the following: mouse anti-GFP 
(Roche), rabbit anti-α-fetoprotein (AFP, Biomeda), goat anti-Albumin (Sigma), fluorescein 
isothiocyanate (FITC)- conjugated Dolichos biflorus agglutinin (DBA) lectin (Sigma), rabbit 
anti-α-1-Antitrypsin (Sigma), rabbit anti-CYP3A2 (Biomol), rabbit anti-CYP7A1 (Santa Cruz), 
mouse anti-Oct3/4 (Santa Cruz) Secondary antibodies used were Alexa 568-conjugated goat 
anti-rabbit, donkey anti-goat antibodies (Molecular Probes); Alexa 488-conjugated goat 
anti-mouse and anti-rabbit, donkey anti-goat antibodies (Molecular Probes). Cells were 
counterstained with DAPI (Roche). The numbers of stained cells in Figure 3 were quantified by 
analyzing, the areas of AFP-positive staining images using Lumina Vision program (Mitani 
Corporation) (Supplementary Table 2) 
  
Period acid Schiff (PAS) analysis  
The cultured cells were fixed in 3.3% formalin for 10 min, and intracellular glycogen was 
stained using a PAS staining solution (Muto Pure Chemicals), according to the manufacturer’s 
instructions.  
 
 
Albumin secretion assay 
The culture media were replaced with fresh media and the conditioned media were harvested 
24 hours later and were assayed for Albumin secretion using the Lebis ELISA kit (Shibayagi). 
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Assay for cytochrome P450 3A activity 
To confirm cytochrome P450 3A activity, 3μg samples of microsomes were analyzed using the 
P450-GloTM CYP3A4 Assay Kit (Promega).  Microsomes were prepared from livers of 
6-week-old male ICR mice, undifferentiated ES cells, and differentiated ES cells.  The protein 
content of the microsome preparations was measured using the Micro BCATM Protein Assay Kits 
(Pierce). 
 
Transmission Electron Microscopy 
Human ES cell-derived hepatic cells grown on M15 in tissue culture plates for 50 days were 
fixed with 2% glutaldehyde-cacodylate buffer for 30 min, postfixed with 1% osmium tetroxide 
for 30 min, after which they were dehydrated with graded series of ethanol. Samples were 
embedded in Epok 812 (Oken Trading, Tokyo, Japan), and ultrathin sections were cut with an 
ultramicrotome (MT7000-Ultra; RMC, Tucson, AZ, USA).  Samples were stained with uranyl 
acetate and lead citrate and were then viewed with an electron microscope (H-7500; Hitachi, 
Tokyo, Japan). 
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FIGURE LEGENDS 
Figure 1 
Modification of the previous differentiation protocol of ES cells results an efficient 
differentiation of mouse ES cells into Afp expressing hepatic endoderm lineages at the 
expense of Pdx1-expressing cell lineages. 
(A) Quantification by flow cytometry analysis of gut definitive endoderm (E-cadherin+/Cxcr4+) 
or Pdx1/GFP expressing cells.  ES cell were differentiated on M15 cells, added with Activin 
and bFGF at d0-d4.  Then at d4-d8, ES cells were cultured at a combination of various soluble 
factors, in media supplemented with FBS or KSR with varied glucose concentration (2000 or 
4500 mg/L) and were evaluated on d8, for the proportion of definitive endoderm cells defined by 
E-cadherin+/Cxcr4+, or Pdx1-expressing cells using flow cytometry analysis.  (B) Relative Shh 
and Afp transcript levels within E-cadherin+/Cxcr4+ definitive endoderm in the differentiated ES 
cells by real-time PCR analysis.  Gut definitive endoderm (E-cadherin+/Cxcr4+) cells were 
separated using flow cytometry. cDNA from these definitive endoderm cells  were used as 
templates.  Shh and Afp transcript levels were quantified and normalized against those of 
β-actin.  The results are compared with that of controls in 4500FBS (the differentiated ES cells 
grown under conditions with 4500mg/L glucose, 10%FBS and without growth factors), which is 
defined as 1. (A, B) Control (white bars; without growth factors), Activin&bFGF (black bars; 
with 20 ng/ml Activin and 50ng/ml bFGF), Dex&HGF&OsM (gray bars; with 1 μM 
dexamethasone, 10 ng/ml HGF and 10ng/ml Oncostatin M).  2000FBS (2000mg/L glucose, 
10%FBS), 2000KSR (2000mg/L glucose, 10%KSR), 4500FBS (4500mg/L glucose, 10%FBS), 
4500KSR (4500mg/L glucose, 10%KSR). 
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Figure 2 Effects of various factors on the formation of ES cell-derived Pdx1/GFP- or 
AFP-expressing cells were compared by immunocytochemical analysis.  
(A) ES cells cultured for 8 days were stained for AFP (red) and GFP (Pdx1; green).  The effects 
of various factors added on d4-d8 are compared.  ES cells were differentiated on M15 cells, 
added with Activin & bFGF on d0-d4.  On d4-d8, Activin & bFGF were withdrawn and the 
following culture conditions were tested: control (without any factors); Activin & bFGF (with 
Activin and bFGF), Dex & HGF & OsM (with Dex, HGF and OsM), and cultured in medium 
with KSR or FBS, at a glucose concentration at 2000 or 4500 mg/ml (2000FBS, 2000KSR, 
4500FBS, 4500KSR).  Bars indicate 200 μm.  (B) Quantitative analysis of the effects of Dex, 
HGF and OsM on hepatic differentiation.  On d4-d8, addition of one, or combinations of two 
factors, or all three factors were added to the ES cell cultures in 2000KSR condition.  Fold 
increases in AFP-positive cells compared to control.  AFP-positive area was analyzed using a 
Lumina Vision program.  (C, D) BMP and FGF signals are pivotal for hepatic differentiation of 
the definitive endoderm from ES cells. ES cells were allowed to differentiate with Activin and 
bFGF in media supplemented with Activin and bFGF, 10% FBS and 4500 mg/L glucose on 
d0-d4, then switched to 10% KSR and 2000 mg/L glucose, with or without the indicated growth 
factors.  (C) ICC analysis using anti-AFP antibodies, with DAPI counterstained the nuclei.  
The addition of Noggin inhibited differentiation into AFP-positive cells, but bFGF addition 
rescued the inhibitory effect of Noggin.  Bars indicate 200 μm.  (D) Fold increase in AFP 
positive cells compared to control.  AFP positive region in each fluorescence image was 
analyzed using Lumina Vision program.  Values represent means ± standard error of the mean 
(n=3).  *p < 0.05 and **p < 0.01 vs control by Student’s t-test. 
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Figure 3 Chronological analysis revealed a sequential induction of hepatic cells 
recapitulating normal hepatic development. 
ES cells were differentiated at d0-d4 in media supplemented with Activin and bFGF, 10% FBS 
and 4500 mg/L glucose.  At d4-d8, the supplements were switched to Dex, and HGF, 10% KSR 
and 2000 mg/L glucose.  (A) Differentiated ES cells on d10, d18, d22 and d30 were stained for 
AFP (green) and Albumin (red).  On d10, AFP+ hepatoblast like cells arise (d10, green).  
AFP+/Albumin+ cells appeared at d18 of differentiation (d18, merged as yellow).  On d22, 
AFP-/Albumin+ mature hepatocytes increased (d22, red), while AFP+ cells (d22, green) reduced 
in number.  On d30, AFP+ cells almost disappeared and Albumin+ cells form distinct colonies.  
(B) Differentiated ES cells on d30 were stained for Albumin (a hepatocyte marker, red) and 
Dolichos biflorus agglutinin (DBA) lectin (a bile duct marker, green).  Albumin+ and DBA 
lectin+ cells were detected in colonies distinct from each other.  (C) Differentiated ES cells on 
d30 were stained for Albumin (green) and mature hepatocyte markers (red): α 1-Antitrypsin, 
Cyp3A and Cyp7A1.  Bars indicate 200 μm.  
 
Figure 4 Molecular analysis of hepatic molecular markers by real-time PCR of ES 
cell-derived hepatocytes compared with those from fetal liver or adult liver. 
Transcripts of hepatic marker genes were quantified by real-time PCR analyses.  ES cells were 
differentiated on d0-d4 in media supplemented with Activin and bFGF, 10% FBS and 4500 mg/L 
glucose.  On d4-d30, the supplements were switched to Dex, and HGF, 10% KSR and 2000 
mg/L glucose.  The transcript level was normalized with that of β-actin.  Each value is 
normalized with that of the differentiated ES cells on d30 (d30) and thus the graphs represent 
relative gene expression level when the level on d30 is defined as 100.  ES cells were cultured 
on optimal condition for hepatic differentiation, with Dex and HGF.  M15; M15 cells, ES; 
undifferentiated ES cells, d10 and d30; differentiated ES cells grown on M15 ells at d10 and d30, 
FL; CD45-/Ter199- E12.5 fetal liver cells , AL; adult liver.  
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Figure 5 Analyses of ES cell-derived hepatocytes. 
ES cells were cultured on optimal condition for hepatic differentiation, with OsM.  ES cells 
were differentiated on d0-d4 in media supplemented with Activin and bFGF, 10% FBS and 4500 
mg/L glucose.  (A) On d4-d30, the supplements were switched to Dex, and HGF, 10% KSR and 
2000 mg/L glucose (Dex&HGF/2000KSR).  (B) On d4-8; Dex&HGF/2000KSR, on d8-60; 
Dex&HGF/2000KSR or Dex&HGF&OsM/2000KSR.  (C) On d4-8; Dex&HGF/2000KSR, on 
d8-60 Dex&HGF&OsM/2000KSR.  (A) Periodic acid Schiff assay performed on d30 
differentiated ES cells indicates numerous hepatocytes within the colonies with cytoplasm 
glycogen storage (dark red), whereas not detected in differentiated ES cells on d4 or M15 cells.  
(B) Albumin-secreting potential of ES cell-derived hepatic cells was assayed with ELISA.  The 
differentiation medium was changed to fresh medium 24h before assay.  The amount of albumin 
released from the ES cell-derived hepatic cells into the medium per 24 hours was measured in 
each medium on d8, d40, d50 and d60 of differentiation.  (C) Cytochrome P450 3A4 activity of 
ES cell-derived hepatic cells.  Each value is normalized with the amount of protein and thus the 
graphs represent relative activity when the activity of adult liver is defined as 1.  ES; 
undifferentiated ES cells, d60; differentiated ES cells grown on M15 cells on d60, AL; adult liver.  
Values represent means ± standard error of the mean (n=3). 
 
Figure 6 Differentiation of human ES cells into hepatic lineages  
Differentiated human ES cells (KhES-1) on d10, grown on M15 cells, supplemented with 20 
ng/ml Activin, 10μM LY294002, 10% KSR and 4500 mg/L glucose.  On d10, supplements were 
switched to 1 μM Dex and 10 ng/ml HGF.  (A) RT-PCR analysis of endoderm or hepatic 
markers in differentiated ES cells.  hES; undifferentiated human ES cells, d18 and d30; 
differentiated human ES cells grown on M15 cells at d18 and d30, M15; M15 cells.  (B) 
Differentiated ES cells on d14, 18 and 30 were stained for AFP (green) and Albumin (red).   
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Figure 7 Analyses of human ES cell-derived hepatocytes. 
(A) Transcripts of hepatic marker genes were quantified by real-time PCR analyses.  The 
transcript level was normalized with that of Gapdh.  Each value is normalized with that of the 
differentiated ES cells on d50 (d50) and thus the graphs represent relative gene expression level 
when the level on d50 is defined as 100.  hES; undifferentiated human ES cells, d18 and d50; 
differentiated ES cells grown on M15 cells on d18 and d50, FL; human fetal liver (22-40 weeks 
old), AL; human adult liver (51 years old).  (B) PAS staining performed on d24 and 50 
differentiated ES cells indicates numerous hepatocytes within the colonies with cytoplasmic 
glycogen storage (dark red).  Bars indicate 200 μm.  (C-E) Transmission electron microscopy 
of ES-derived differentiated cells on d50.  Micrograph of hepatocytes derived from human ES 
cells indicated hepatocyte ultrastructure described in the text.  Notes, Bc, bile canaliculus, En, 
endosome, Fi, intracellular filament, g, glycogen, Go, Golgi apparatus, Ly, lysosome, Mt, 
mitochondria, N, nucleus, sER, smooth endoplasmic reticulum and rER, rough endoplasmic 
reticulum.  The arrows in C and E indicated cell junction complexes, and arrowheads in F 
indicate microvilli.  Scale bars in C, D, and E were 6.7 µm, 667 nm, 2 µm, respectively. 
 
 







Table 1. PCR primers used to detect mouse gene expressions 
Gene  Forward primer   Reverse primer    
mouse 
Abcb11 (Bsep)  GAGTGGTGGACAGAAGCAAA  TGAGGTAGCCATGTCCAGAA 
Afp  TCGTATTCCAACAGGAGG  AGGCTTTTGCTTCACCAG   
Alb1  CTTAAACCGATGGGCGATCTCACT  CCCCACTAGCCTCTGGCAAAAT 
β-actin  GTGATGGTGGGAATGGGTCA  TTTGATGTCACGCACGATTTCC   
Cyp2b10  GCCCAATGTTTAGTGGAGGA  GACTTCTCCTTCTCCATGCG 
Cyp3a11  ATAGAGCTTTGCTGTCCCCC  CGGCTTTCCTTCATTCTGTC 
Cyp3a13  CCCTGCTGTCTCCAACCTT  TGCGATTCTCTTTCATTCGTT 
Cyp7a1  CAACGGGTTGATTCCATACC  ATTTCCCCATCAGTTTGCAG 
Krt7  GGCGCTGGACATTGAGA   CCATGGTTCCTCCGAAGATA 
Krt19  GTCCTACAGATTGACAATGC  CACGCTCTGGATCTGTGACAG 
Pdx1  CCAAAACCGTCGCATGAAGTG  CTCTCGTGCCCTCAAGAATTTTC   
Slco1a4 (Oatp2) GACGGCTCAGTGTTCATTC  CTTCTAGCTGGTCCCTCTT 
Sult2a1  GGAAGGACCACGACTCATAAC  GATTCTTCACAAGGTTTGTGTTACC 
Ugt1a1  TCTGAGCCCTGCATCTATCTG  CCCCAGAGGCGTTGACATA 
 
human 
Afp  TGCCAACTCAGTGAGGACAA  TCCAACAGGCCTGAGAAATC 
Alb  GATGTCTTCCTGGGCATGTT  ACATTTGCTGCCCACTTTTC 
CK7  TCGCTGAGGTCAAGGCACAG  CACTCCTCAGCCTCGGCAAT 
CK18  CCATGCGCCAGTCTGTGGAG  GTGGTGCTCTCCTCAATCTGCT 
CK19  TGAGGTCATGGCCGAGCAGAAC  CATGAGCCGCTGGTACTCCTGA 
Cyp3a4  CAGGAGGAAATTGATGCAGTTTT           GTCAAGATACTCCATCTGTAGCACAGT 
Cyp7a1  AATTCCATACCTGGGCTGTG  AGGCAGCGGTCTTTGAGTTA 
Gapdh  CGAGATCCCTCCAAAATCAA  CATGAGTCCTTCCACGATACCAA 
Oatp1b1  TGAACACCGTTGGAATTGC                  TCTCTATGAGATGTCACTGGAT 
Oct4  AGGTGTGGGGGATTCCCCCAT  GCGATGTGGCTGATCTGCTGC 
Sox17  ACTGCAACTATCCTGACGTG  AGGAAATGGAGGAAGCTGTT 
ABcb11, ATP-binding cassette sub-family B member 11; Afp, α-fetoprotein; Alb1, albumin1; Krt7(CK7), 
cytokeratin 7; CK18, cytokeratin 18; Krt19(CK19), cytokeratin 19; Pdx1; pancreatic and duodenal 
homeobox 1, Sult2a1, sulfotransferase family 2A dehydroepiandrosterone-preferring member 1; Ugt1a1, 
UDP glucuronosyltransferase 1 family polypeptide A1 
Table 2. Immunocytochemical analysis of protein expression in ES cell derived hepatic cells
Data represent mean ±SEM of three samples.
Mouse ES (%)                         
AFP  33.1±1.7 7.4±0.9
Albumin        0      17.8±1.3  
DBA         0      72.9±3.8
Oct3/4 8.2±0.9       0                   0  
AFP  40.4±3.6 79.4±2.8 58.5±5.1       
Albumin        0  0.8±0.1 9.0±1.2
Human ES (%)
d8             d30 d14             d20               d40  Antigen Antigen
